Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Calidi Biotherapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get CLDI alerts

About Eric Poma

Eric Poma is recorded as Board Member at Calidi Biotherapeutics, Inc. (CLDI) since April 22, 2025 and CEO at Calidi Biotherapeutics, Inc. (CLDI). Calidi Biotherapeutics, Inc. reported in an 8-K filed April 23, 2025 that Eric Poma was appointed CEO, effective April 22, 2025. Calidi Biotherapeutics, Inc. reported in an 8-K filed April 23, 2025 that Eric Poma was appointed Class I director, effective April 22, 2025. Eric Poma has spoken on 1 investor event across 1 company, most recently for Calidi Biotherapeutics, Inc. on November 7, 2025. Calidi Biotherapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Calidi Biotherapeutics, Inc. includes Eric Poma, Ph.D. (CEO and Board Member), Thomas A. Vecchiolla (CEO and Chairman), James Schoeneck (Chairman and Board Member) and 7 others.

“On April 17, 2025, the Board, by a unanimous vote, appointed Eric Poma, Ph.D. to serve as CEO of the Company, effective April 22, 2025.”
Calidi Biotherapeutics, Inc. Form 8-K, filed April 23, 2025 · Read the filing
“In addition, on April 22, 2025, the Board, upon recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Dr. Poma to serve as a Class I director of the Company, also effective April 22, 2025, with a term expiring at the annual meeting of stockholders to be held in 2027.”
Calidi Biotherapeutics, Inc. Form 8-K, filed April 23, 2025 · Read the filing

Eric Poma on recent calls

“We wanted to highlight why we're so excited about the technology. Again, we think that we have a really unique approach here to systemic delivery by creating this engineered, selected form of vaccinia virus that can evade immune surveillance.”
CEO, 2025 SITC Investor Day Presentation ·

Affiliation history

Company network

Leadership on record at Calidi Biotherapeutics, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2024 Calidi Biotherapeutics, Inc. (CLDI) — —
2023 Calidi Biotherapeutics, Inc. (CLDI) — —

Recent activity